Skip to content

The application of liposomal bupivacaine in fascia iliaca compartment block for hip arthroplasty

The application of liposomal bupivacaine in fascia iliaca compartment block for hip arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101962
Enrollment
Unknown
Registered
2025-05-06
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip replacement

Interventions

Bupivacaine liposomal group:Before anesthesia, perform bupivacaine liposome iliac fascia compartment block on patients undergoing hip replacement surgery
Ropivacaine group:Ropivacaine iliac fascia compartment block before anesthesia for patients undergoing hip replacement surgery

Sponsors

Nanjing Pukou District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age range 65 to 80 years old, American Society of Anesthesiologists (ASA) classification I-III, preoperative iliac fascia compartment block, no contraindications for postoperative rehabilitation training

Exclusion criteria

Exclusion criteria: Patients with severe organ dysfunction, combined with other injuries, allergic reactions to the study drug, skin infections at the puncture site, severe coagulation dysfunction, and postoperative ICU monitoring and treatment, as well as patients who refuse rehabilitation training after surgery

Design outcomes

Primary

MeasureTime frame
Intraoperative dosages of sufentanil and remifentanil;VAS scores at rest and during rehabilitation exercise on the day after surgery, the first day, the second day, and the third day;The daily dosage of opioid drugs, NSAIDs, and other analgesic drugs on the day, first day, second day, and third day after surgery;;The time when the patient starts getting out of bed;

Countries

China

Contacts

Public ContactZheng Kang

Nanjing Pukou District Traditional Chinese Medicine Hospital

robertzheng@163.com+86 133 2781 9101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026